Oral Solid Medications

Full Tech Transfer and localization of oral solid medications which cover mainly the chronic diseases (diabetes, hyperlipidemia, cardiovascular. Etc…).


Pharma & Biotech
Download Opportunity

Thank you for your interest in the Invest Saudi.

We received your enquiry, and we will get back to you shortly.

Investment Highlights

  • Expected Investment size of USD 3.5 Billion for the whole segment and not capex / plant- (capex/ plant is 75 Million)
  • Plant capacity: Subjected to review ktpa
  • Expected IRR: - Subjected to review %
  • Payback period: Subjected to review years
  • Job Creation: 588 till 2035 (Source NIS)
  • GDP Impact: Subjected to review %

More Pharma & Biotech opportunities